Stem Cell Technology

Vitro Biopharma is presently focused on adult stem cells known as mesenchymal stem cells or MSCs. The discovery of embryonic stem cells capable of differentiation into any cell type of the body was largely responsible for the development of modern stem cell technology. Embryonic stem cells are also ethically contentious since, in certain cases, embryo destruction results from the use of embryonic stem cells. However, adult stem cells are derived through non-destructive procedures from a variety of tissue sources.  Adult stem cells have been approved for clinical use for over 50 years and have a strong record of safety and efficacy for use in the treatment of numerous blood disorders and immunological conditions. Presently, the MSC sector of stem cell research is one of the most rapidly growng and expanding fields within the entire stem cell industry.

The rapid emergence of stem cell products & technology based on MSCs is related to several factors including the widespread availability of these cells from numerous tissue sources and the strong clinical results showing preliminary efficacy and safety in a broad range of indications within disease treatment, recovery from injury and accelerated healing as well as numerous applications in regenerative medicine.

Our stem cell products and technology are based upon MSCs.  We offer basic tools to support stem cell research and clinical studies of MSCs.  Our products include both native MSCs and various derivatives, our MSC-Gro™specialty cell culture media for support of growth and differentiation of MSCs and measurement tools for several aspects of stem cell quality and ability to treat certain conditions.  Our MSC cell lines include native cells, fluorescent-labeled MSCs for use in tracking studies and in-vivo imaging experiments together with terminally differentiated cells derived from MSCs including osteoblasts, chondrocytes, neural stem cells, nephron progenitor cells and cardiomyocytes.  We also provide various Cancer-Associated Fibroblasts (CAFs) & native fibroblasts for advanced cancer research.